Abliva Financial Statements From 2010 to 2025
| NEVPFDelisted Stock | USD 0.03 0.00 0.00% |
Check Abliva AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abliva AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Abliva financial statements analysis is a perfect complement when working with Abliva AB Valuation or Volatility modules.
Abliva |
Abliva AB Company Return On Equity Analysis
Abliva AB's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Abliva AB Return On Equity | -0.8 |
Most of Abliva AB's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abliva AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Abliva AB has a Return On Equity of -0.805. This is 96.64% lower than that of the Healthcare sector and 97.79% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 159.68% higher than that of the company.
Abliva AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abliva AB's current stock value. Our valuation model uses many indicators to compare Abliva AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abliva AB competition to find correlations between indicators driving Abliva AB's intrinsic value. More Info.Abliva AB is rated below average in return on equity category among its peers. It is regarded fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abliva AB's earnings, one of the primary drivers of an investment's value.About Abliva AB Financial Statements
Abliva AB stakeholders use historical fundamental indicators, such as Abliva AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although Abliva AB investors may analyze each financial statement separately, they are all interrelated. For example, changes in Abliva AB's assets and liabilities are reflected in the revenues and expenses on Abliva AB's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Abliva AB. Please read more on our technical analysis and fundamental analysis pages.
Abliva AB develops medicines for the treatment of primary mitochondrial diseases. Abliva AB was incorporated in 2000 and is headquartered in Lund, Sweden. ABLIVA AB is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Abliva Pink Sheet
If you are still planning to invest in Abliva AB check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Abliva AB's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |